Finland· FI-REL-REL56149
Klisyri
A tirbanibulin product containing tirbanibulin, registered in Finland by Almirall S.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Tirbanibulin is registered in 12 of 19 countries.
Countries holding a registration under ATC D06BX03 (tirbanibulin), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Tirbanibulin · ATC D06BX03
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Tirbanibulin
- Manufacturer
- Almirall S.A.
- Country
- Finland (FI)
- ATC code
- D06BX03
- ATC class
- Tirbanibulin
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tirbanibulin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKlisyriAlmirall, LLC
- SpainKLISYRI 10 MG/G POMADAAlmirall S.A.
- IcelandKlisyriAlmirall S.A.*
- CzechiaKLISYRIAlmirall, S.A., Barcelona
- PolandKlisyriAlmirall, S.A.
- SwedenKlisyri 10 mg/g SalvaAlmirall S.A.
- NetherlandsKlisyri 10 mg/g, zalfGrupo Farmacéutico Almirall S.A.
- United KingdomKlisyri 10mg/g ointment 250mg sachetsAlmirall Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Klisyri
- Liechtenstein · Klisyri
- Norway · Klisyri
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df1f4a33-fb88-4da0-936b-2f552ae73bd2 GET /v1/drugs/df1f4a33-fb88-4da0-936b-2f552ae73bd2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "voide",
"route": "Iholle",
"ddd_unit": null,
"strength": "10 mg/g",
"atc_label": "tirbanibuliini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/21/1558/001",
"fimea_rel_id": "REL56149",
"authorised_at": "2021-07-16"
}See everything about tirbanibulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.